IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
Amwill Health Care IPO is a book build IPO listing on BSE SME exchange. The company is based in Bangalore and caters to Healthcare - Personal Care sector. Unistone Capital Private is the merchant banker of Amwill Health Care IPO. It is a SME IPO which filed its Draft Red Herring Prospectus (DRHP) on 18th May 2024.
Amwill Health Care IPO posted revenues of Rs 46.50 crores and PAT of Rs 13.04 crores in FY25 on annualised basis.Financial results of Amwill Health Care IPO based on restated financials as per prospectus and IPO review parameters can be referred to below.
Amwill Health Care IPO PAT Margin is 28.15%, ROCE (Return on Capital Employed) is 36.16% as per latest financial. The below table shows Amwill Health Care IPO Key Performance Indicators (KPI) as mentioned in company’s prospectus.
The market Capitalisation of Amwill Health Care IPO is Rs 222.04 crores at the time of IPO and other IPO valuation metrics of this IPO is mentioned below.
The Amwill Health Care IPO prospectus highlights an Return on Equity (ROE) of 15%, Return on Assets (ROA) of 12%, and an EBITDA Margin of 18%, showcasing financial performance.
Profitability ratios like Return on Equity (ROE), Return on Assets (ROA), and Net Profit Margin shows Amwill Health Care IPO financial report. Analysing these metrics can provide insights into the company’s efficiency, profitability, and long-term growth potential.
The post-IPO market capitalisation of Amwill Health Care IPO is ₹222.04 Cr, based on the issue price and share structure. It helps investors gauge the company’s valuation and compare it with industry peers before investing.
The Amwill Health Care IPO has a Price-to-Earnings (PE) ratio of 17.04 X, indicating valuation compared to industry peers. It helps investors determine if the stock is overvalued or undervalued compared to its earnings and industry peers.
Amwill Health Care IPO reported revenue of ₹46.50 Cr in the latest fiscal year, showing business performance, on annualised basis. Revenue figures from Amwill Health Care IPO provide insights into sales growth, market demand, and business scalability.
Amwill Health Care recorded an EBITDA of ₹ 17.68 Cr., reflecting operational efficiency. EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortisation) measures operational profitability.
Amwill Health Care Profit After Tax (PAT) is ₹13.04 Cr, reflecting earnings growth. Profit After Tax (PAT) reflects the company’s actual earnings after all expenses, taxes, and deductions
Revenue:
₹ 46.32 Cr.
EBITDA Margin:
38.17
%
Net Worth: ₹ 23.68 Cr.
Market Capitalisation:
₹ 222.04 Cr.
P/E:
17.04 times
P/BV: 2.65 times
EV/EBITDA: 11.81 times
Amwill Health Care operates in Healthcare - Personal Care and Development Of Generic Dermatological Solutions. The Issue is listed on BSE SME in Feb, 2025. Amwill Health Care IPO size was 59.98 with Issue price of 111.00 .
Merchant Banker(s) of Amwill Health Care IPO: Unistone Capital Private Limited
Amwill Health Care IPO subscription was 5.73 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Amwill Health Care IPO listed at a listing price of 88.85 against the offer price of 111.00.
The current market price of Amwill Health Care is 81.78.
Why Us?
